Literature DB >> 29752166

Circulating matrix modulators (MMP-9 and TIMP-1) and their association with severity of diabetic retinopathy.

Kuppuswami Jayashree1, Md Yasir1, Gandhipuram Periyasamy Senthilkumar2, K Ramesh Babu3, Vadivelan Mehalingam4, Palani Selvam Mohanraj1.   

Abstract

AIMS: Diabetic Retinopathy (DR) is the leading cause of vision loss in the working age population. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1), are molecules involved in extracellular tissue matrix remodelling. They are implicated in the loss of retinal tissue integrity, a major cause of DR, that leads to retinal tissue degradation and apoptosis. This study is therefore, conducted to compare the serum levels of MMP-9 and TIMP-1 in T2DM patients without and with retinopathy, and to evaluate their association with the severity of DR.
MATERIALS AND METHODS: Our study comprised of 2 groups of 41 each. Group A (cases) included T2DM patients with retinopathy and Group B (controls) included T2DM patients without retinopathy. Routine parameters, mainly, fasting blood glucose, and lipid profile were measured using autoanalyzer. Serum MMP-9, TIMP-1, and insulin levels were assessed using ELISA method. RESULTS AND
CONCLUSION: Statistically significant increase in the levels of MMP-9, insulin, fasting blood glucose and lipid profile were observed in the serum of T2DM patients with retinopathy, as compared with those without retinopathy. These results help to conclude that rise in MMP-9, and associated serum markers promote disease progress in DR. These findings suggest that the elevations of our study markers in the serum of the type 2 diabetic patients with retinopathy, as compared to those without retinopathy, play important roles in aggravating tissue matrix degradation, supporting DR disease progression.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Diabetic retinopathy; Insulin; Insulin resistance; Matrix Metalloproteinase-9; Tissue Inhibitor of Metalloproteinase-1

Mesh:

Substances:

Year:  2018        PMID: 29752166     DOI: 10.1016/j.dsx.2018.05.006

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  9 in total

Review 1.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

Review 2.  Metalloproteinases mediate diabetes-induced retinal neuropathy and vasculopathy.

Authors:  Ghislain Opdenakker; Ahmed Abu El-Asrar
Journal:  Cell Mol Life Sci       Date:  2019-06-10       Impact factor: 9.261

3.  Network pharmacology-based strategy for predicting therapy targets of Sanqi and Huangjing in diabetes mellitus.

Authors:  Xiao-Yan Cui; Xiao Wu; Dan Lu; Dan Wang
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

4.  Comparison of matrix metalloproteinase 9 and 14 levels in vitreous samples in diabetic and non-diabetic patients: a case control study.

Authors:  A Ünal; O Baykal; N Öztürk
Journal:  Int J Retina Vitreous       Date:  2022-06-21

5.  A Potential Participant in Type 2 Diabetes Bone Fragility: TIMP-1 at Sites of Osteocyte Lacunar-Canalicular System.

Authors:  Qilin Pei; Jun Li; Pengfei Zhou; Jun Zhang; Peng Huang; Jingchuan Fan; Zhen Zou; Xi Li; Bin Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-12-23       Impact factor: 3.168

Review 6.  Retinal capillary basement membrane thickening: Role in the pathogenesis of diabetic retinopathy.

Authors:  Sayon Roy; Dongjoon Kim
Journal:  Prog Retin Eye Res       Date:  2020-09-18       Impact factor: 21.198

7.  Serum Anti-Collagen IV IgM and IgG Antibodies as Indicators of Low Vascular Turnover of Collagen IV in Patients with Long-Term Complications of Type 2 Diabetes.

Authors:  Krasimir Kostov; Alexander Blazhev
Journal:  Diagnostics (Basel)       Date:  2021-05-19

8.  Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus.

Authors:  Lucia Saucedo; Isabel B Pfister; Souska Zandi; Christin Gerhardt; Justus G Garweg
Journal:  Mediators Inflamm       Date:  2021-06-25       Impact factor: 4.711

Review 9.  Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes Extracellular Matrix Remodeling.

Authors:  Bessi Qorri; Regina-Veronicka Kalaydina; Aleksandra Velickovic; Yekatrina Kaplya; Alexandria Decarlo; Myron R Szewczuk
Journal:  Cells       Date:  2018-08-26       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.